查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1614347

Finasteride市场：依适应症、通路划分 - 2025-2030 年全球预测

Finasteride Market by Indication (Androgenetic Alopecia, Benign Prostatic Hyperplasia), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年Finasteride市值为1.1968亿美元，预计2024年将达到1.2288亿美元，复合年增长率为2.81%，预计到2030年将达到1.454亿美元。

Finasteride是一种主要用于治疗良性前列腺增生（BPH）和雄性秃的药物，脱髮症在泌尿系统和皮肤科的双重治疗用途而受到关注。Finasteride的需求是由于与男性老化相关的良性前列腺增生的增加以及对毛髮生长剂的需求不断增长。其用途包括用于治疗 BPH 的口服锭剂和用于治疗脱髮的局部製剂。最终用途范围涵盖医疗保健部门，例如医院、专科诊所和零售药房，所有这些对于向民众分发Finasteride至关重要。市场成长的主要驱动力是人口老化、雄性秃脱髮症的增加、医疗保健意识的提高以及配方技术的进步。最新的成长机会包括扩大地理覆盖范围，特别是在医疗基础设施正在改善的亚太地区和拉丁美洲。公司可以利用这一点，透过进行策略性合併来扩大其市场份额。然而，专利到期和替代治疗的可用性也面临增加市场竞争的挑战。此外，性功能障碍等副作用可能会限制接受度。各地区的监管障碍也带来了挑战。有前景的创新领域包括开发先进的给药系统以提高药物疗效并最大限度地减少副作用，探索联合治疗以提高治疗效果，以及製定有针对性的营销策略，其中包括人工智能主导分析的整合。此外，对Finasteride治疗疾病的遗传易感性研究的更多关注可能会开拓新的细分市场。总体而言，Finasteride市场是动态的，具有透过策略扩张和创新来实现成长的潜力，但应采取平衡的方法，透过仔细评估监管环境和消费者的看法来最大限度地发挥市场潜力。

主要市场统计
基准年[2023] 11968万美元
预计年份 [2024] 12288万美元
预测年份 [2030] 1.454 亿美元
复合年增长率（%） 2.81%

市场动态：揭示快速发展的Finasteride市场的关键市场洞察

Finasteride市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 雄性秃和脱髮症护腺疾病的盛行率增加
    • 增加市场准入的支持性监管政策
  • 市场限制因素
    • 原材料短缺影响生产扩充性
  • 市场机会
    • Finasteride生产技术的进步
    • Finasteride的治疗用途大幅扩展
  • 市场挑战
    • 缺乏技术纯熟劳工

波特的五力：驾驭非Finasteride市场的策略工具

波特的五力架构是了解Finasteride市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对Finasteride市场的影响

外部宏观环境因素在塑造Finasteride市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解非Finasteride市场的竞争状况

对Finasteride市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵Finasteride市场供应商绩效评估

FPNV定位矩阵是评估Finasteride市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製您在非Finasteride市场的成功之路

Finasteride市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 男性型脱髮症和摄护腺疾病增加
      • 增加市场准入的支持性监管政策
    • 抑制因素
      • 原材料短缺影响生产扩充性
    • 机会
      • Finasteride生产技术的进步
      • Finasteride的治疗用途大幅扩展
    • 任务
      • 缺乏技术纯熟劳工
  • 市场区隔分析
    • 适应症：Finasteride在男性型脱髮症的采用率很高，使其成为长期治疗的选择
    • 通路：网路药局的出现成为寻求隐私和便利的病患的便利选择
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 非Finasteride市场的适应症

  • 雄性脱髮症
  • 良性摄护腺增生

第七章Finasteride市场：依通路划分

  • 医院药房
  • 网路药房
  • 零售药房

第八章 美洲非Finasteride市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章 亚太地区Finasteride市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲Finasteride市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Zydus 获得美国 FDA核准Finasteride和他达拉非胶囊
    • Zydus Lifesciences 透过收购英国Liqmeds Group 扩大全球影响力
    • Bluewater Vaccines 收购 Verus Pharmaceuticals 的 Entadfi 胶囊部门
  • 战略分析和建议

公司名单

  • Accord Healthcare US. by Intas Pharmaceuticals
  • Apotex Inc.
  • Aurobindo Pharma USA, Inc.
  • Camber Pharmaceuticals, Inc. by Hetero Labs Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Endo, Inc.
  • Hanmi Pharmaceutical Co., LTD.
  • Merck KGaA
  • Niksan Life Sciences Private Limited
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceuticals USA, Inc.
  • Torrent Pharmaceuticals Ltd.
  • Veru Inc.
  • Viatris Inc.
  • WELLONA PHARMACEUTICAL PRIVATE LIMITED
  • Zydus Group.
Product Code: MRR-CD5A9334D4CB

The Finasteride Market was valued at USD 119.68 million in 2023, expected to reach USD 122.88 million in 2024, and is projected to grow at a CAGR of 2.81%, to USD 145.40 million by 2030.

Finasteride, a medication primarily used to treat benign prostatic hyperplasia (BPH) and male pattern baldness, has garnered attention due to its dual therapeutic applications in urology and dermatology. The necessity for Finasteride arises from the growing incidence of BPH in aging males and increased demand for hair regrowth solutions. Its application extends to both oral tablets for BPH management and topical formulations for hair loss treatment. End-use scope encompasses healthcare sectors like hospitals, specialty clinics, and retail pharmacies, all pivotal in dispensing Finasteride to the population. Market growth is largely driven by the aging demographic trend, increasing prevalence of androgenetic alopecia, and rising healthcare awareness, coupled with technological advancements in drug formulations. Latest opportunities for growth include expanding geographic access, especially in Asia-Pacific and Latin America, where healthcare infrastructure is improving. Companies could capitalize on this by engaging in strategic mergers to expand market presence. However, the Finasteride market is challenged by patent expirations and the availability of alternative therapies, which increase market competition. Additionally, side effects such as sexual dysfunction may limit its acceptance. Regulatory hurdles across various regions also pose challenges. Promising areas of innovation include developing advanced delivery systems to improve the drug's efficacy and minimize side effects, exploring combination therapies for enhanced outcomes, and integrating AI-driven analytics for targeted marketing strategies. Furthermore, an increased focus on research concerning genetic predispositions to conditions treated with Finasteride could unlock new market segments. Overall, the Finasteride market is dynamic, with potential for growth through strategic expansion and innovation, yet it necessitates careful navigation of regulatory landscapes and consumer perceptions, ensuring a balanced approach to leverage its full market potential.

KEY MARKET STATISTICS
Base Year [2023] USD 119.68 million
Estimated Year [2024] USD 122.88 million
Forecast Year [2030] USD 145.40 million
CAGR (%) 2.81%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Finasteride Market

The Finasteride Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of androgenetic alopecia and prostate disorders
    • Supportive regulatory policies enhancing market accessibility
  • Market Restraints
    • Raw material scarcity impacting production scalability
  • Market Opportunities
    • Advancements in production technologies for finasteride
    • Significant expansion of finasteride in therapeutic applications
  • Market Challenges
    • Shortage of skilled workforce

Porter's Five Forces: A Strategic Tool for Navigating the Finasteride Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Finasteride Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Finasteride Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Finasteride Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Finasteride Market

A detailed market share analysis in the Finasteride Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Finasteride Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Finasteride Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Finasteride Market

A strategic analysis of the Finasteride Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Finasteride Market, highlighting leading vendors and their innovative profiles. These include Accord Healthcare US. by Intas Pharmaceuticals, Apotex Inc., Aurobindo Pharma USA, Inc., Camber Pharmaceuticals, Inc. by Hetero Labs Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., Endo, Inc., Hanmi Pharmaceutical Co., LTD., Merck KGaA, Niksan Life Sciences Private Limited, Sun Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc., Torrent Pharmaceuticals Ltd., Veru Inc., Viatris Inc., WELLONA PHARMACEUTICAL PRIVATE LIMITED, and Zydus Group..

Market Segmentation & Coverage

This research report categorizes the Finasteride Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Androgenetic Alopecia and Benign Prostatic Hyperplasia.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of androgenetic alopecia and prostate disorders
      • 5.1.1.2. Supportive regulatory policies enhancing market accessibility
    • 5.1.2. Restraints
      • 5.1.2.1. Raw material scarcity impacting production scalability
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in production technologies for finasteride
      • 5.1.3.2. Significant expansion of finasteride in therapeutic applications
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled workforce
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Indication: High adoption of finasteride in androgenetic alopecia a long-term treatment option
    • 5.2.2. Distribution Channel: Emergence of online pharmacies as a convenient option for patients seeking privacy and ease
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Finasteride Market, by Indication

  • 6.1. Introduction
  • 6.2. Androgenetic Alopecia
  • 6.3. Benign Prostatic Hyperplasia

7. Finasteride Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospital Pharmacies
  • 7.3. Online Pharmacies
  • 7.4. Retail Pharmacies

8. Americas Finasteride Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Finasteride Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Finasteride Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Zydus Secures USFDA Approval for Finasteride and Tadalafil Capsules
    • 11.3.2. Zydus Lifesciences Expands Its Global Reach with Acquisition of UK-Based Liqmeds Group
    • 11.3.3. Blue Water Vaccines Acquires Verus Pharmaceuticals' Entadfi Capsules Division
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accord Healthcare US. by Intas Pharmaceuticals
  • 2. Apotex Inc.
  • 3. Aurobindo Pharma USA, Inc.
  • 4. Camber Pharmaceuticals, Inc. by Hetero Labs Limited
  • 5. Cipla Limited
  • 6. Dr. Reddy's Laboratories Ltd.
  • 7. Endo, Inc.
  • 8. Hanmi Pharmaceutical Co., LTD.
  • 9. Merck KGaA
  • 10. Niksan Life Sciences Private Limited
  • 11. Sun Pharmaceutical Industries Limited
  • 12. Teva Pharmaceuticals USA, Inc.
  • 13. Torrent Pharmaceuticals Ltd.
  • 14. Veru Inc.
  • 15. Viatris Inc.
  • 16. WELLONA PHARMACEUTICAL PRIVATE LIMITED
  • 17. Zydus Group.

LIST OF FIGURES

  • FIGURE 1. FINASTERIDE MARKET RESEARCH PROCESS
  • FIGURE 2. FINASTERIDE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FINASTERIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FINASTERIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FINASTERIDE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FINASTERIDE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES FINASTERIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES FINASTERIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. FINASTERIDE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. FINASTERIDE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FINASTERIDE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FINASTERIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FINASTERIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FINASTERIDE MARKET DYNAMICS
  • TABLE 7. GLOBAL FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FINASTERIDE MARKET SIZE, BY ANDROGENETIC ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FINASTERIDE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FINASTERIDE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FINASTERIDE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES FINASTERIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. FINASTERIDE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. FINASTERIDE MARKET, FPNV POSITIONING MATRIX, 2023